Neutralizing Antibody Activity Against the B.1.617.2 (delta) Variant Before and After a Third BNT162b2 Vaccine Dose in Hemodialysis Patients

Hemodialysis patients are at high risk for severe COVID-19, and impaired seroconversion rates have been demonstrated after COVID-19 vaccination. Humoral immunity wanes over time and variants of concern with immune escape are posing an increasing threat. Little is known about protection against the B...

Descripción completa

Detalles Bibliográficos
Autores principales: Benning, Louise, Klein, Katrin, Morath, Christian, Bartenschlager, Marie, Kim, Heeyoung, Buylaert, Mirabel, Reineke, Marvin, Töllner, Maximilian, Nusshag, Christian, Kälble, Florian, Reichel, Paula, Schnitzler, Paul, Zeier, Martin, Süsal, Caner, Bartenschlager, Ralf, Schaier, Matthias, Speer, Claudius
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931261/
https://www.ncbi.nlm.nih.gov/pubmed/35309320
http://dx.doi.org/10.3389/fimmu.2022.840136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931261/
https://www.ncbi.nlm.nih.gov/pubmed/35309320
http://dx.doi.org/10.3389/fimmu.2022.840136

Ejemplares similares